Masataka Sata

Latest

Nocturnal blood pressure and left ventricular hypertrophy in patients with diabetes mellitus
Not a small frog in a big pond: targeting bradykinin receptor B2 signaling in vascular smooth muscle cells for treatment of hypertension
Optimizing antihypertensive therapy in patients with diabetes mellitus
NLRP3 Inflammasome Activation Through Heart-Brain Interaction Initiates Cardiac Inflammation and Hypertrophy During Pressure Overload
Give a Leg Up: Screening for Peripheral Artery Disease after Acute Myocardial Infarction
Linking RNA dynamics to heart disease: the lncRNA/miRNA/mRNA axis in myocardial ischemia-reperfusion injury
Pathogenic Basis of Thromboinflammation and Endothelial Injury in COVID-19: Current Findings and Therapeutic Implications
Biodegradable Extremely-Small-Diameter Vascular Graft Made of Silk Fibroin can be Implanted in Mice
Vildagliptin, a DPP-4 Inhibitor, Attenuates Endothelial Dysfunction and Atherogenesis in Nondiabetic Apolipoprotein E-Deficient Mice
Activation of Toll-Like Receptor 9 Impairs Blood Flow Recovery After Hind-Limb Ischemia
Toll-Like Receptor 9 Plays a Pivotal Role in Angiotensin II-Induced Atherosclerosis
Obesity-induced DNA released from adipocytes stimulates chronic adipose tissue inflammation and insulin resistance
Endothelial PGC-1α mediates vascular dysfunction in diabetes
HMGB1 plays a critical role in vascular inflammation and lesion formation via toll-like receptor 9
Toll-like receptor-2 mediates adaptive cardiac hypertrophy in response to pressure overload through interleukin-1β upregulation via nuclear factor κB activation
The ATP-binding cassette transporter ABCG2 protects against pressure overload-induced cardiac hypertrophy and heart failure by promoting angiogenesis and antioxidant response
Aliskiren in combination with valsartan exerts synergistic protective effects against ventricular remodeling after myocardial infarction in mice
The ATP-binding cassette transporter BCRP1/ABCG2 plays a pivotal role in cardiac repair after myocardial infarction via modulation of microvascular endothelial cell survival and function
Candesartan ameliorates cardiac dysfunction observed in angiotensin-converting enzyme 2-deficient mice
Reversible left ventricular hypertrophy after tako-tsubo-like cardiomyopathy